name | fqc |
sex | male
|
age | 81 岁 |
hospital number | 858294 |
height | 173 cm |
weight | 61 kg |
BSA | 1.76 m2 |
APACHEⅡ | 23 分 |
Infection source | lung
|
date | 2018/1/8 年/月/日 |
Sequential Organ Failure Assessment | 10 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
/urine volume≥0.5
|
age>=60 | yes
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | no
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | no
|
yes
|
|
no
|
|
yes
|
|
no
|
|
yes
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
亚胺培南西司他丁钠1g ivgtt q8h |
|
vasoactive agent | norepinephrine
|
100 min |
|
150 min |
|
180 min |
Temperature | 37.8 ℃ |
Heart Rate | 100 次/分 |
Breath | 23 次/分 |
Systolic pressure (SP) | 135 mmHg |
Diastolic pressure | 73 mmHg |
mean arterial pressure | 96 mmHg |
Pcv-aCO2 | 13.5 mmHg |
DO2 | 539.81 |
VO2 | 136.18 |
Ca-vO2 | 44.08 |
pH value | 7.33 |
PaO2 | 49 mmHg |
PaCO2 | 49.9 mmHg |
BE | -0.4 mmol/L(±2.3mmol/L) |
SaO2 | 100.20 % |
Blood lactic acid concentration, LAC | 2.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 81.67 mmHg |
pH value | 7.27 |
PcvO2 | 47.2 mmHg |
PcvCO2 | 63.4 mmHg |
BE | 0.5 mmol/L |
ScvO2 | 74.9 % |
Volume of input | 0 ml |
Volume of output | 0 ml |
Volume of urine | 0 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 0.5 μg/Kg/min |
dopamine | no
|
Dopamine Dosage | μg/Kg/min |
Dobutamine | Yes
|
Dobutamine Dosage | 5 μg/Kg/min |
CVP | 8 mmHg |
cardiac output | 3.09 L/min |
cardiac index | 1.76 L/min/m2 |
stroke volume | 32 ml |
Stroke Index | 17.6 ml/m2 |
ITBVI | 923 ml/m2 |
GEDVI | 778 ml/m2 |
EVLWI | 8.9 ml/kg |
PVPI | 1.7 |
SVRI | 4008 DSm2/cm5 |
CFI | 2 |
GEF | 9 % |
SVV | 12 % |
PPV | % |
dPmax | 1226 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 3 条 |
LUS | 5 分 |
B+ Zone | 1 区 |
IVC(inspiratory phase) | 15 mm |
IVC(expiratory phase) | 10.2 mm |
respiratory variations of inferior vena cavae diameter | 38.1 % |
mm |
|
mm |
|
mm |
|
mm |
- Inferior Vena Cava
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
IVC(inspiratory phase) | 16 mm |
IVC(expiratory phase) | 12 mm |
Respiratory variations of inferior vena cavae diameter | 28.57 % |
mm |
|
mm |
|
mm |
|
mm |
Temperature | 37.2 ℃ |
Heart Rate | 176 次/分 |
Breath | 20 次/分 |
Systolic Pressure | 107 mmHg |
Diastolic Pressure | 62 mmHg |
Mean Arterial Pressure | 79 mmHg |
Pcv-aCO2 | 8.7 mmHg |
DO2 | 523.62 |
VO2 | 123.29 |
Ca-vO2 | 36.52 |
PH value | 7.32 |
PaO2 | 97.8 mmHg |
PaCO2 | 51.2 mmHg |
BE | -0.8 mmol/L |
SaO2 | 97.5 % |
Blood Lactic Acid Concentration | 1.1 mmol/L |
Oxygenation index (PaO2/FiO2) | 217.33 mmHg |
PH value | 7.28 |
PcvO2 | 48.3 mmHg |
PcvCO2 | 59.5 mmHg |
BE | 0 mmol/L |
ScvO2 | 74.5 % |
Volume of input | 1028 ml |
Volume of output | 450 ml |
Volume of urine | 400 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 10 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | 100 mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 10 mmHg |
cardiac output | 3.39 L/min |
cardiac index | 1.93 L/min/m2 |
stroke volume | 38 ml |
Stroke Index | 22.4 ml/m2 |
ITBVI | 932 ml/m2 |
GEDVI | 746 ml/m2 |
EVLWI | 6.2 ml/kg |
PVPI | 12 |
SVRI | 2864 DSm2/cm5 |
CFI | 3 |
GEF | 9 % |
SVV | 22.4 % |
PPV | % |
dPmax | 882 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 2 条 |
LUS | 3 分 |
B+ Zone | 1 区 |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37 ℃ |
Heart Rate | 122 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 139 mmHg |
Diastolic Pressure | 74 mmHg |
Mean Arterial Pressure | 97 mmHg |
Pcv-aCO2 | 7.9 mmHg |
DO2 | 898.81 |
VO2 | 214.42 |
Ca-vO2 | 34.81 |
PH value | 7.35 |
PaO2 | 103 mmHg |
PaCO2 | 44.4 mmHg |
BE | -1.5 mmol/L |
SaO2 | 98.3 % |
Blood Lactic Acid Concentration | 1 mmol/L |
Oxygenation index (PaO2/FiO2) | 228.89 mmHg |
PH value | 7.31 |
PcvO2 | 46.8 mmHg |
PcvCO2 | 52.3 mmHg |
BE | -0.8 mmol/L |
ScvO2 | 74.8 % |
Volume of input | 1500 ml |
Volume of output | 680 ml |
Volume of urine | 600 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 15 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | 200 mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 10 mmHg |
cardiac output | 6.19 L/min |
cardiac index | 3.52 L/min/m2 |
stroke volume | 42 ml |
Stroke Index | 28.8 ml/m2 |
ITBVI | 941 ml/m2 |
GEDVI | 753 ml/m2 |
EVLWI | 8 ml/kg |
PVPI | 1.6 |
SVRI | 1978 DSm2/cm5 |
CFI | 1206 |
GEF | 15 % |
SVV | 17 % |
PPV | % |
dPmax | 5 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 2 条 |
LUS | 4 分 |
B+ Zone | 1 区 |
IVC(inspiratory phase) | 18 mm |
IVC(expiratory phase) | 16 mm |
Respiratory variations of inferior vena cavae diameter | 11.76 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.8 ℃ |
Heart Rate | 93 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 133 mmHg |
Diastolic Pressure | 75 mmHg |
Mean Arterial Pressure | 96 mmHg |
Pcv-aCO2 | 5.40 mmHg |
DO2 | 783.82 |
VO2 | 157.28 |
Ca-vO2 | 30.27 |
PH value | 7.38 |
PaO2 | 135 mmHg |
PaCO2 | 47.9 mmHg |
BE | 2.5 mmol/L |
SaO2 | 99.4 % |
Blood Lactic Acid Concentration | 1.7 mmol/L |
Oxygenation index (PaO2/FiO2) | 300.00 mmHg |
PH value | 7.36 |
PcvO2 | 50.9 mmHg |
PcvCO2 | 53.3 mmHg |
BE | 3.1 mmol/L |
ScvO2 | 79.4 % |
Volume of input | 2321 ml |
Volume of output | 2300 ml |
Volume of urine | 2350 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 30 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | 250 mg |
Milrinone Dosage | 30 mg |
Levosimendan | no
|
CVP | 11 mmHg |
cardiac output | 5.24 L/min |
cardiac index | 2.98 L/min/m2 |
stroke volume | 45 ml |
Stroke Index | 32 ml/m2 |
ITBVI | 1233 ml/m2 |
GEDVI | 986 ml/m2 |
EVLWI | 1.5 ml/kg |
PVPI | 1 |
SVRI | 2283 DSm2/cm5 |
CFI | 3 |
GEF | 14 % |
SVV | 18 % |
PPV | % |
dPmax | 747 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 2 条 |
LUS | 6 分 |
B+ Zone | 1 区 |
IVC(inspiratory phase) | 16 mm |
IVC(expiratory phase) | 12 mm |
Respiratory variations of inferior vena cavae diameter | 28.57 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.1 ℃ |
Heart Rate | 66 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 119 mmHg |
Diastolic Pressure | 61 mmHg |
Mean Arterial Pressure | 82 mmHg |
Pcv-aCO2 | mmHg |
DO2 |
|
VO2 |
|
Ca-vO2 |
|
PH value |
|
PaO2 | mmHg |
PaCO2 | mmHg |
BE | mmol/L |
SaO2 | % |
Blood Lactic Acid Concentration | mmol/L |
Oxygenation index (PaO2/FiO2) | mmHg |
PH value |
|
PcvO2 | mmHg |
PcvCO2 | mmHg |
BE | mmol/L |
ScvO2 | % |
Volume of input | 4050 ml |
Volume of output | 4250 ml |
Volume of urine | 4100 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 35 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | 300 mg |
Milrinone Dosage | 30 mg |
Levosimendan | no
|
CVP | 8 mmHg |
cardiac output | 4.25 L/min |
cardiac index | 2.41 L/min/m2 |
stroke volume | 41 ml |
Stroke Index | 36.6 ml/m2 |
ITBVI | 1069 ml/m2 |
GEDVI | 856 ml/m2 |
EVLWI | 11.2 ml/kg |
PVPI | 1.9 |
SVRI | 2450 DSm2/cm5 |
CFI | 3 |
GEF | 17 % |
SVV | 8 % |
PPV | % |
dPmax | 804 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 2 条 |
LUS | 7 分 |
B+ Zone | 2 区 |
IVC(inspiratory phase) | 18 mm |
IVC(expiratory phase) | 15 mm |
Respiratory variations of inferior vena cavae diameter | 18.18 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | ℃ |
Heart Rate | 次/分 |
Breath | 次/分 |
Systolic Pressure | mmHg |
Diastolic Pressure | mmHg |
Mean Arterial Pressure | mmHg |
Pcv-aCO2 | 5.4 mmHg |
DO2 | 0 |
VO2 | 0 |
Ca-vO2 | 36.42 |
PH value | 7.47 |
PaO2 | 57 mmHg |
PaCO2 | 40.4 mmHg |
BE | 5.7 mmol/L |
SaO2 | 87 % |
Blood Lactic Acid Concentration | 1.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 142.50 mmHg |
PH value | 7.44 |
PcvO2 | 38.7 mmHg |
PcvCO2 | 45.8 mmHg |
BE | 6.1 mmol/L |
ScvO2 | 62.1 % |
Volume of input | 5891 ml |
Volume of output | 5800 ml |
Volume of urine | 5650 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 35 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | 300 mg |
Milrinone Dosage | 30 mg |
Levosimendan | no
|
CVP | mmHg |
cardiac output | L/min |
cardiac index | L/min/m2 |
stroke volume | ml |
Stroke Index | ml/m2 |
ITBVI | ml/m2 |
GEDVI | ml/m2 |
EVLWI | ml/kg |
PVPI |
|
SVRI | DSm2/cm5 |
CFI |
|
GEF | % |
SVV | % |
PPV | % |
dPmax |
|
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(expiratory phase) | mm |
Respiratory variations of inferior vena cavae diameter | % |
IVC(inspiratory phase) | mm |
mm |
|
mm |
|
mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | pg/ml |
cTNI | 0.034 ng/ml |
Creatine kinase isoenzyme, CKMB | 16 U/L |
Creatinine | 98 umol/L |
Urea nitrogen | 14.4 mmol/l |
MDRD | ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 33.5 X10*9/L |
neutrophilic granulocyte percentage | 86.4 % |
Hb | g/L |
CRP | 136.21 mg/L |
Procalcitonin, PCT | 3.267 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 16 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | 15 U/L |
Creatinine | 88 umol/L |
Urea nitrogen | 21 mmol/l |
MDRD | ml/min/1.73m2 |
WBC | 23.3 X10*9/L |
neutrophilic granulocyte percentage | 93.7 % |
Hb | g/L |
CRP | 100.67 mg/L |
Procalcitonin, PCT | 2.13 ng/ml |
Sequential Organ Failure Assessment | 15 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | 5 U/L |
Creatinine | 68 umol/L |
Urea nitrogen | 18.2 mmol/L |
MDRD | ml/min/1.73m2 |
WBC | 17.7 X10*9/L |
neutrophilic granulocyte percentage | 89.5 % |
Hb | g/L |
CRP | 42.58 mg/L |
Procalcitonin, PCT | ng/ml |
Sequential Organ Failure Assessment | 12 分 |
Transfusion of Red Cells | no
|
Transfusion of Red Cells | U |
Plasma infusion | no
|
Plasma infusion | ml |
platelet transfusion | no
|
platelet transfusion | U |
APACHEⅡ | 10 分 |
Complication | no
|
prognosis | department transference
|
28-day mortality | no
|
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 25 天 |
duration in ICU | 4 天 |
duration of mechanical ventilation | 79 小时 |
ICU expenses | 28550 元 |
Continuous Renal Replacement Therapy | no
|
Continuous Renal Replacement Therapy | 0 小时 |